nad has been researched along with Respiratory Distress Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Ignjatovic, A; Milenkovic, J; Milojkovic, M; Stojanovic, D; Stojanovic, M; Velickov, A | 1 |
| Giles, R; Mustafa, F; Pepper, MS | 1 |
| Lee, JY; Migaud, M; Stevens, RP; Stevens, T | 1 |
| Fang, L; Ji, Z; Liu, H; Yu, Y; Zhou, Z | 1 |
| Camp, SM; Deaton, R; Gann, PH; Garcia, JG; Letsiou, E; Ma, W; Machado, RF; Messana, J; Moreno-Vinasco, L; Quijada, H; Saadat, L; Sammani, S; Siegler, J; Wang, T; Zaidi, RS | 1 |
| Konno, K; Nagai, A; Ozawa, Y; Uno, H; Yasui, S | 1 |
| Caputi, AP; Cuzzocrea, S; Dugo, L; Mazzon, E; McDonald, MC; Serraino, I; Thiemermann, C; Threadgill, M | 1 |
2 review(s) available for nad and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Renalase Challenges the Oxidative Stress and Fibroproliferative Response in COVID-19.
Topics: COVID-19; Cytokines; Fibrosis; Humans; Monoamine Oxidase; NAD; Oxidative Stress; Reactive Oxygen Species; Respiratory Distress Syndrome; Sirtuins | 2022 |
Rapid evolution of our understanding of the pathogenesis of COVID-19: Implications for therapy.
Topics: Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents; Anticoagulants; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Cytokine Release Syndrome; HLA Antigens; Humans; Immunization, Passive; Inflammation; NAD; Oxidative Stress; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome; Thrombophilia; Vitamins | 2020 |
5 other study(ies) available for nad and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Salvaging the endothelium in acute respiratory distress syndrome: a druggable intersection between TLR4 and NAD
Topics: Endothelium; Humans; NAD; Respiratory Distress Syndrome; Signal Transduction; Toll-Like Receptor 4 | 2021 |
Use of immunoproteomics to identify immunogenic proteins in a rat model of acute respiratory distress syndrome.
Topics: Animals; Autoantibodies; Cecum; Choline; Computational Biology; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Gluconeogenesis; Glycolysis; Heme; Humans; Lung; Male; NAD; Punctures; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Signal Transduction | 2017 |
Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury.
Topics: Acrylamides; Animals; Anti-Inflammatory Agents; Apoptosis; Bronchoalveolar Lavage Fluid; Caspase 3; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Inflammation Mediators; Lung; Mice; Mice, Inbred C57BL; NAD; Neutrophils; Nicotinamide Phosphoribosyltransferase; Piperidines; Pneumonia; Respiratory Distress Syndrome; Ventilator-Induced Lung Injury | 2014 |
Niacin attenuates acute lung injury induced by lipopolysaccharide in the hamster.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cricetinae; Disease Models, Animal; Endotoxins; Escherichia coli; Lipopolysaccharides; Male; Mesocricetus; NAD; Niacin; Respiratory Distress Syndrome | 1994 |
Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury.
Topics: Animals; Cell Survival; Cytokines; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Intercellular Adhesion Molecule-1; Isoquinolines; Mice; Mice, Inbred BALB C; NAD; P-Selectin; Peroxynitrous Acid; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Respiratory Distress Syndrome; Up-Regulation | 2002 |